Related Experiment Video

Updated: Dec 21, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Prognostic factors in chronic hypersensitivity pneumonitis

Andrew W Creamer¹, Shaney L Barratt²

¹Bristol Interstitial Lung Disease Service, Southmead Hospital, North Bristol NHS Trust, Bristol, UK andrew.creamer@nhs.net.

European Respiratory Review : an Official Journal of the European Respiratory Society

|May 17, 2020

Summary

Identifying prognostic factors for hypersensitivity pneumonitis (HP) is crucial. Older age, poor lung function, and fibrosis predict worse survival in chronic HP patients, highlighting the need for better predictive tools.

Area of Science:

Pulmonology
Immunology
Environmental Medicine

Background:

Hypersensitivity pneumonienstis (HP) is an immune-mediated lung disease caused by inhaled antigens.
A significant subset of HP patients develop progressive fibrosis, leading to respiratory failure and death.
Accurate prognostic factors are needed to guide patient management and improve survival outcomes.

Purpose of the Study:

To conduct a narrative review of existing evidence.
To identify prognostic factors associated with disease outcome and survival in patients with chronic HP.

Main Methods:

A comprehensive literature search was performed.
Existing retrospective studies were analyzed to identify reported prognostic indicators.

Main Results:

Patient demographics, smoking history, antigen exposure, and comorbidities are associated with HP outcomes.
Physiological, radiological, and laboratory markers predict overall survival.
Older age, impaired pulmonary function, and evidence of fibrosis (biopsy or HRCT) are consistently linked to worse survival.

Conclusions:

While no single marker is definitive, several factors predict worse outcomes in chronic HP.
There is a critical need for prospective, longitudinal studies to identify factors predicting nonfatal deterioration.
Future research should focus on developing HP-specific composite scores for improved prognostic accuracy.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

Related Concept Videos

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Articles linked to this work by shared authors, journal, and citation graph.

Visibility of breathlessness in fibrotic interstitial lung disease: perceptions of international healthcare professionals.

ERJ open research·2026

Protocol for the INterstitial lung Disease EXacerbations (INDEX) Study: a retrospective multicentre cohort study.

BMJ open respiratory research·2026

The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.

Rheumatology (Oxford, England)·2026

Pulmonary cystic destruction in systemic sclerosis and antisynthetase syndrome associated non-specific interstitial pneumonitis: a case series of a novel radiological phenotype.

Rheumatology advances in practice·2026

Validation of pre-flight algorithms in predicting hypoxic challenge testing (HCT) outcomes in interstitial lung disease (ILD).

Therapeutic advances in respiratory disease·2026

European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

The European respiratory journal·2025

See all related articles